ACACIA PHARMA, INC.

BARHEMSYS

Manufacturer:

ACACIA PHARMA, INC.

Barhemsys HCPCS:

C9153

HCPCS Code Descriptor:

Injection, amisulpride, 1 mg

Category:

C Code

Barhemsys NDCs:

No actively aligned NDCs found

Primary Type:

Anti-Emetic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Barhemsys CPT Codes:

Potential CPT administration codes for Barhemsys can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Barhemsys:

BARHEMSYS is an Anti-Emetic drug manufactured by Acacia Pharma and administered via the intravenous route of administration. The C Code: C9153 is aligned to the drug BARHEMSYS.

ACCESS PRICING AND MORE BY REGISTERING

C9153 Added Date:

October 1, 2023

C9153 Effective Date:

October 1, 2023

C9153 Termination Date:

December 31, 2023

We have not yet identified a manufacturer source of Barhemsys billing and coding information.
Our team did not identify a source for Barhemsys patient assistance information. Please reach out to our team if you feel that this is a mistake.
BARHEMSYS prescribing information can be found at the link below:
Information regarding BARHEMSYS’s side effects can be found at MedlinePlus

BuyandBill.com Drug Alert: